Table 1. Studies showing statistically significant correlations of V2-specific antibodies that correlate with protection from and/or control of HIV, SIV and SHIV.
Year | Protection and/or control of | Correlation with Abs specific for | Immunization | Reference |
2012 | HIV SIVmac251 | V2i V2p | Active Active | Haynes et al. [32] Barouch et al. [44] |
2013 | HIV SIVmac251 | V2p V2p | Active Active | Gottardo et al. [43] Pegu et al. [45] |
2014 | SIVmac251 | V2p | Active | Gordon et al. [46] |
2015 | SIVE660 | V2p | Active | Roederer et al. [47] |
2016 | SIVmac251 | V2p | Active | Vaccari et al. [48] |
2018 | SHIVBaL SIVsmE66 SHIVBaL SHIVBaL | V2i V2p V2 V2p | Passive Active Active Active | Hessell et al. [49▪] Singh et al. [50] Hessell et al. [51] Weiss et al. [52▪] |